Literature DB >> 3729725

Effect of Moloney murine leukemia virus on the carcinogenicity of 3-methylcholanthrene in normal rat kidney cells.

Y Hassan, M Huleihel, E Priel, K Rosner, M Aboud.   

Abstract

Normal rat kidney (NRK) cell were found to be resistant to neoplastic transformation by diverse carcinogenic chemicals. To study chemical-retroviral co-carcinogenesis in this cells they were infected with a low multiplicity of Moloney murine leukemia virus (M-MLV). Using a single cell cloning procedure, a virus-producing clone was isolated from the infected cells, which was shown to carry only one integrated M-MLV provirus per cell. It was found that this single provirus was sufficient to render the clone susceptible to transformation by 3-methylcholanthrene (3-MC). However this clone responded differently to the carcinogen at different passages after infection. When exposed to 3-MC at a low passage postinfection (passage 5), cell transformation was evident only after 11 subsequent subcultures. On the other hand when it was chemically treated at a high passage postinfection (passage 29), cell transformation could clearly be detected already at the next subculture after the chemical treatment. It is suggested that an M-MLV-mediated cumulative effect is necessary to complement the action of the carcinogen in order to complete the carcinogenic process in these cells. This cumulative viral effect appeared to be associated with a change in the control of the virus expression, since 3-MC was found to stimulate virus replication in this clone also only at the high passage postinfection. Indeed virus release by cells of isolated transformed foci, produced by the chemical-M-MLV co-carcinogenesis, was extremely higher than by untransformed cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729725     DOI: 10.1007/bf01314145

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  CHROMOSOMAL ABERRATIONS IN VIRAL LEUKEMOGENESIS. I. FRIEND AND RAUSCHER LEUKEMIA.

Authors:  R TSUCHIDA; M A RICH
Journal:  J Natl Cancer Inst       Date:  1964-07       Impact factor: 13.506

2.  Current concepts on mechanisms of chemical carcinogenesis.

Authors:  I B Weinstein
Journal:  Bull N Y Acad Med       Date:  1978-04

3.  Sister chromatid exchanges induced in vivo and in vitro by chemical carcinogens in mouse lymphocytes carrying endogenized Moloney leukemia virus.

Authors:  F Majone; A Montaldi; F Ronchese; A De Rossi; L Chieco-Bianchi; A G Levis
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Type C RNA tumor viruses as determinants of chemical carcinogenesis: effects of sequence of treatment.

Authors:  P J Price; W A Suk; A E Freeman
Journal:  Science       Date:  1972-09-15       Impact factor: 47.728

6.  An effect of interferon on the uncoating of murine leukaemia virus not related to the antiviral state.

Authors:  M Aboud; R Shoor; S Salzberg
Journal:  J Gen Virol       Date:  1980-12       Impact factor: 3.891

7.  mRNA transcripts related to full-length endogenous retroviral DNA in human cells.

Authors:  A B Rabson; P E Steele; C F Garon; M A Martin
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

8.  Partial inhibition of postreplication repair and enhanced frequency of chemical transformation in rat cells infected with leukemia virus.

Authors:  R Waters; N Mishra; N Bouck; G DiMayorca; J D Regan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

9.  Effect of mouse interferon on cell transformation and virus production in rat cells exogenously infected with moloney murine sarcoma and leukemia viruses.

Authors:  M Huleihel; M Aboud
Journal:  Int J Cancer       Date:  1982-04-15       Impact factor: 7.396

10.  Inhibition of retrovirus DNA supercoiling in interferon-treated cells.

Authors:  M Huleihel; M Aboud
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.